Latest News
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye disease with innovative small molecules to preserve, slow, or restore vision loss.
Latest Financial Results
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2025
IR Contacts
Headquarters
Kiora Pharmaceuticals, Inc.
169 Saxony Rd
Suite 212
Encinitas, CA 92024